Mebeverine SR Pellets Manufacturer India

Mebeverine  SR Pellets (CAS No: 2753-45-9) — Sustained Release Multiparticulates

Mebeverine HCl SR Pellets are sustained-release pharmaceutical pellets manufactured from Mebeverine Hydrochloride (C₂₅H₃₆ClNO₅, MW ≈466.0), a musculotropic antispasmodic used in gastrointestinal smooth-muscle-spasm conditions such as irritable bowel syndrome (IBS). Swapnroop Drugs and Pharmaceuticals manufactures Mebeverine HCl SR Pellets at its WHO-GMP certified Aurangabad, Maharashtra facility, supplying pharmaceutical formulators across India and export markets in 25+ countries.

Formulation Approach
Mebeverine HCl SR pellets are produced by layering the drug onto an inert or drug-crystal core followed by a rate-controlling functional polymer coat, calibrated to deliver an extended-release profile suited to once- or twice-daily antispasmodic capsule formulations.

Key Features

• Sustained-release multiparticulate antispasmodic formulation
• Drug substance is the hydrochloride salt of Mebeverine, a smooth-muscle relaxant
• Suitable for hard-gelatin capsule filling and multiparticulate tablet compression
• WHO-GMP manufactured with full batch documentation

Applications

• Irritable Bowel Syndrome (IBS) and GI smooth-muscle spasm formulations
• Sustained-release antispasmodic capsule development
• Generic ANDA/CTD dossier programs requiring dissolution-matched SR profiles

Why Choose Swapnroop for Mebeverine SR Pellets?

• WHO-GMP certified Aurangabad facility with drug-layering and functional-coating capability
• Full CoA, MSDS, and DMF-grade documentation for USFDA, EMA, and CDSCO submissions
• Export experience across 40+ countries

FAQs

• What condition is Mebeverine HCl typically used for? It is a musculotropic antispasmodic most commonly used for IBS-related GI smooth-muscle spasm.
• Is a specific mesh size available? Confirm current SDP offering — mesh/particle size is set per formulation requirement.

Get Bulk Quote via WhatsApp